Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cardiovascular, Cardiac, Cardiology, Cardiometabolic Companies _ Imaging, Diagnostics, Health IT & Medical Devices
Prevencio Inc.*

Organization & Developments: Prevencio

Parents

*Biomarkers produce novel, multi-protein, algorithmically-scored tests, enabling clinicians to assess heart attack, stroke, and cardiac death.
*Developer of multi-proteomic biomarkers designed for blood tests for cardiovascular disease.
2017: How A New Blood Test by Prevencio and MGH Could Forecast Heart Attacks
2017: In addition to the Hart CAD test for diagnosis, Prevencio is developing blood tests for predicting, and ideally preventing, the likelihood that a patient will have a heart attack, stroke, or cardiovascular death within one year.
2017: Prevencio is developing its standardized lab test for Hart CAD and plans to conduct FDA trials in 2018, then file for European and FDA approval between 2018 and 2019.